The future of cytopathology in Europe. Will the wider use of HPV testing have an impact on the provision of cervical screening?
Version of Record online: 20 SEP 2007
Volume 18, Issue 5, pages 278–282, October 2007
How to Cite
Gray, W., Bayer-Pietsch, E., Chieco, P., Cochand Priollet, B., Desai, M., Drijkoningen, M., Griffin, M., Hagmar, B., Kapila, K., Kloboves-Prevodnik, V., Kobayashi, T., Krogerus, L., Majak, B., Mihailovici, M., Olszewski, W., Schenck, U., Schmitt, F., Shabalova, I., Shapiro, N., Smith, J., Tani, E., Totsch, M., Vass, L., Wiener, H. and Herbert, A. (2007), The future of cytopathology in Europe. Will the wider use of HPV testing have an impact on the provision of cervical screening?. Cytopathology, 18: 278–282. doi: 10.1111/j.1365-2303.2007.00487.x
- Issue online: 20 SEP 2007
- Version of Record online: 20 SEP 2007
- Accepted for publication 4 June 2007
- cervical screening;
- HPV testing;
- quality control;
- European experience
Abstract: The emphasis of the EFCS Congress held in Venice in October 2006 was on the future of Cytopathology in relation to events in Europe. Much of the discussion centred on the role of human papilloma virus testing and its impact on the provision of cervical screening. The following is a transcript of the discussion that took place at the Advisory Board Meeting for the journal Cytopathology, with some additional written comments received prior to the meeting. A brief summary has been provided as a conclusion by Dr A. Herbert.